Personalised breast cancer therapy and the ALLTO trial

Bookmark and Share
Published: 16 Sep 2009
Views: 13709
Dr Joanne Zujewski - Head of Breast Cancer Therapeutics, NCI, USA
Dr Joanne Zujewski, Head of Breast Cancer Therapeutics at the National Cancer Institute, USA, talks to ecancer at the 1st IMPAKT meeting about the BIG group, ALLTO trial, personalised medicine and coordinating cross-atlantic research.